pre-IPO PHARMA

COMPANY OVERVIEW

Sprial Therapeutics is a late pre-clinical stage company developing first-in-class therapies targeting inner ear disorders.


LOCATION

  • Brisbane, CA, USA

  • THERAPEUTIC AREAS

  • Neurological DIsorders

  • WEBSITE

    https://www.spiraltx.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    camden-partners savoir-capital


    PRESS RELEASES


    Aug 30, 2023

    Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology


    Mar 29, 2023

    Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board


    Jan 9, 2023

    Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière's Disease


    May 6, 2019

    Spiral Therapeutics Closes Series A Financing Totaling $5.6 Million


    Dec 18, 2018

    Spiral Therapeutics Announces First Closing of a Series A Financing and Begins Phase 1 Trial of New Hearing Loss Drug


    For More Press Releases


    Google Analytics Alternative